Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19

S Saqrane; M A El Mhammedi

doi:10.1016/j.nmni.2020.100680

Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19

New Microbes New Infect. 2020 Apr 14;35:100680. doi: 10.1016/j.nmni.2020.100680. eCollection 2020 May.

Authors

S Saqrane¹, M A El Mhammedi²

Affiliations

¹ Sultan Moulay Slimane University, Team of Environmental Microbiology and Toxicology, Laboratory of Chemistry, Modeling and Environmental Sciences, Polydisciplinary Faculty, Khouribga, Morocco.
² Sultan Moulay Slimane University, Team of Analytical Chemistry and Random Modeling, Laboratory of Chemistry, Modeling and Environmental Sciences, Polydisciplinary Faculty, Khouribga, Morocco.

Abstract

Covid-19 disease is caused by SARS-CoV-2, a virus belonging to the coronavirus family. Covid-19 is so new that there is currently no specific vaccine or treatment. Clinical trials are currently underway. In vitro tests are also being conducted to assess the efficacy of chloroquine and hydroxychloroquine for the treatment of this epidemic, which is considered a pandemic by the WHO. We note that the content of this review is dated. The information it contains is subject to change and modification as the epidemic progresses.

Keywords: Chloroquine; Covid-19; coronavirus; epidemic; hydroxychloroquine; treatment.

Publication types

Review